Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 76204-600

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 76204-600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ritedose Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ipra-alb 30 Ct Brick Carton (Rpsc0200 Rdp Ipra Alb 30 Ct Brick Carton Pdf Proof)

This is a description of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution. It is a combination of two medications: ipratropium bromide and albuterol sulfate. The inhalation solution comes in 3 mL vials and is intended for oral inhalation only. Each vial contains approximately 0.5 mg of ipratropium bromide and 3 mg of albuterol sulfate. The inactive ingredients include sodium chloride, 1 N hydrochloric acid (to adjust to pH 4) and water for injection. The medication is in a unit-dose vial, and each box contains 30 vials. Keep out of reach of children. The text includes some unintelligible characters.*

FDA Label Image

60 Ct Brick Carton (Rpsc0201 60 Ct Brick Carton)

This is a description of a drug containing Ipratropium Bromide and Albuterol Sulfate, which is an inhalation solution available in 0.5mg/3mg per 3ml. The text also mentions the dose and method of administration, and contains some unreadable characters.*

FDA Label Image

Ipra-alb 30 Ct Cards Carton (Rpsc0265 Rdp Ipra Alb 30 Ct Cards Carton Pdf Proof New)

NDC 76204-600-05 is a medication for oral inhalation only that contains Ipratropium Bromide and Albuterol Sulfate Inhalation solution. It comes in a box with 30 unit-dose vials, each containing 0.5mg/3mg per 3 mL of solution. The medication should be protected from light and stored between 2°C and 25°C (36°F and 77°F). It is essential to use the medication as directed by the physician and discard it if the solution is not colorless. The patient instructions are to be detached by the pharmacist and dispensed with the solution. This medication is manufactured by The Ritedose Corporation for Ritedose Pharmaceuticals, LLC in Columbia, SC 29203, USA.*

FDA Label Image

Rdp Ipra-alb 60 Ct Cards Carton (Rpsc0266 Rdp Ipra Alb 60 Ct Cards Carton Pdf Proof New)

This is a product description for a medication with the NDC code 76204-600-12, intended for oral inhalation only. It's important to store the unit-dose vials in the protective foil pouch to protect from light and use them within a week of removing them from the pouch. The medication should be discarded if the solution is not colorless, and it should be stored between 2°C and 25°C (36°F and 77°F). The dosage information is provided in accompanying prescribing information and should only be used as directed by a physician. This product contains 60 x 3 mL sterile unit-dose vials (12 pouches of 5 - 3 mL vials each) of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution at a concentration of 0.5mg/3mg per 3mL.*

FDA Label Image

Rdp Ipra-alb 30 Ct Singles Carton (Rpsc0301 Rdp Ipra Alb 30 Ct Singles Carton With New Design Pdf Proof)

This is a description of a drug called NDC 76204-600-01. The drug is an inhalation solution that contains 0.5 mg ipratropium bromide (0.017%) and 3 mg albuterol sulfate (0.083%). Each 3 mL unit-dose vial contains the medication. The solution is intended for oral inhalation only. The drug has been manufactured by Rx Only Redi-Dose and is sold in a package of 30 x 3 mL sterile unit-dose vials. The remaining text contains illegible characters or is not applicable to the description.*

FDA Label Image

Chemical Structure (Ipratropium 01)

FDA Label Image

Chemical Structure (Ipratropium 02)

FDA Label Image

Figure (Ipratropium 03)

FDA Label Image

Figure 1 (Ipratropium 04)

FDA Label Image

Figure 2 (Ipratropium 05)

FDA Label Image

Figures 3 And 4 (Ipratropium 06)

FDA Label Image

Rdp Logo (Ipratropium 07)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.